Citric acid, dextrose, sodium biphosphate, sodium citrate
Sold as Adco-blood primary container with citrate phosphate dextrose adenine a
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 1
- Registrations
- 1
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Adcock Ingram Critical Care (Pty) Ltd | Adco-blood primary container with citrate phosphate dextrose adenine a | Not stated | P0177 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Adco-blood primary container with citrate phosphate dextrose adenine a EACH 100 ml SOLUTION CONTAINS ADENINE 0,0293 CITRIC ACID MONOHYDRATE 0,327 g DEXTROSE MONOHYDRATE 3,19 g SODIUM BIPHOSPHATE 0.251 g SODIUM CITRATE DIHYDRATE, 2,63 g | Not listed | P0177P/8.2/177 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.